Back to feed
TechnologyTechCrunchMarina Temkin

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

At a glance

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Primary source
Read original article
Published
Topic
Technology

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

This summary comes from TechCrunch. Read the full article at the original source.

References